• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of EED mutation in hematologic malignancy

Research Project

Project/Area Number 26460391
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pathological medical chemistry
Research InstitutionKindai University (2016)
Hiroshima University (2014-2015)

Principal Investigator

UEDA Takeshi  近畿大学, 医学部, 講師 (60585149)

Co-Investigator(Kenkyū-buntansha) 本田 浩章  広島大学, 原爆放射線医科学研究所, 教授 (40245064)
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsエピジェネティクス
Outline of Final Research Achievements

EED acts as a non-catalytic component of polycomb repressive complex 2 (PRC2) that is a central regulator of histone H3 Lys27 (H3K27) methylation associated with transcriptional repression. We previously identified EED Ile363Met (I363M) mutation in myelodysplastic syndrome and related diseases. In this study, to investigate the role of I363M in disease pathogenesis, we generated and analyzed EED I363M knock-in mice. As a result, the I363M mutation was shown to inhibit the propagation of trimethylated H3K27 repressive marks in vivo. In addition, we demonstrated that the heterozygotes enhanced hematopoietic stem/progenitor cell activity and contributed to increased susceptibility to leukemia, while the homozygotes resulted in embryonic lethality.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (8 results)

All 2016 2015 2014

All Journal Article (4 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 4 results,  Open Access: 3 results,  Acknowledgement Compliant: 2 results) Presentation (4 results)

  • [Journal Article] Propagation of tri-methylated H3K27 regulated by EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.2016

    • Author(s)
      Ueda T, Nakata Y, Nagamachi A, Yamasaki N, Kanai A, Matsui H, Honda ZI, Oda H, Wolff L, Inaba T, Honda H.
    • Journal Title

      PNAS

      Volume: 113(37) Issue: 37 Pages: 10370-10375

    • DOI

      10.1073/pnas.1600070113

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency2016

    • Author(s)
      Ikeda K-I, Ueda T, Yamasaki N, Nakata Y, Sera Y, Nagamachi A, Miyama T, Kobayashi H, TakuboK, Kanai A, Oda H, Wolff l, Honda Z-1, Ichinohe T, Matsubara A, Suda T, Inaba T, Honda H
    • Journal Title

      Scientific Reports

      Volume: 6 Issue: 1 Pages: 29454-29454

    • DOI

      10.1038/srep29454

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Fbxl10 overexpression in murine hematopoietic stemcells induces leukemia involving metabolic activation and upregulation of Nsg22015

    • Author(s)
      Ueda T, Nagamachi A, Takubo K, Yamasaki N, Matsui H, Kanai A, Nakata Y, Ikeda K Konuma T, Oda H, Wolff L, Honda Z, Wu X, Helin K, Iwama A, Suda T, Inaba T, Honda H.
    • Journal Title

      Blood

      Volume: 125 Issue: 22 Pages: 3437-3446

    • DOI

      10.1182/blood-2014-03-562694

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg22015

    • Author(s)
      Ueda T, Nagamachi A, Takubo K, Yamasaki N, Matsui H, Kanai A, Nakata Y, Ikeda K Konuma T, Oda H, Wolff L, Honda Z, Wu X, Helin K, Iwama A, Suda T, Inaba T, Honda H.
    • Journal Title

      Blood

      Volume: 125

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Presentation] EED変異体によるPRC2活性化障害の造血器腫瘍発症における役割2016

    • Author(s)
      上田健、中田雄一郎、長町安希子、山崎憲政、金井昭教、松井啓隆、稲葉俊哉、本田浩章
    • Organizer
      第89回日本生化学会大会
    • Place of Presentation
      仙台国際センター (宮城)
    • Year and Date
      2016-09-25
    • Related Report
      2016 Annual Research Report
  • [Presentation] ヒストン脱メチル化酵素Fbxl10の白血病発症における機能解析2016

    • Author(s)
      上田健、池田健一郎
    • Organizer
      第20回日本がん分子標的治療学会
    • Place of Presentation
      別府国際コンベンションセンター (大分)
    • Year and Date
      2016-05-31
    • Related Report
      2016 Annual Research Report
  • [Presentation] ヒストン脱メチル化酵素Fbxl10の白血病における機能解析2015

    • Author(s)
      上田 健、長町安希子、中田雄一郎、山崎憲政、稲葉俊哉、本田浩章
    • Organizer
      第38回日本分子生物学会年会、第88回日本生化学大会 合同大会 (ポスター)
    • Place of Presentation
      神戸
    • Year and Date
      2015-12-01
    • Related Report
      2015 Research-status Report
  • [Presentation] Disease-associated EED Ile363Met mutation increases susceptibility to hematologic malignancies2014

    • Author(s)
      上田 健, 長町安希子,中田雄一郎, 山崎憲政, 松井啓隆, 本田浩章
    • Organizer
      第87回日本生化学会大会
    • Place of Presentation
      横浜
    • Year and Date
      2014-10-16
    • Related Report
      2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2020-01-20  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi